|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
51.88(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.06 - $6.77 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 28.8 |
Insider 6 Months : 79.8 |
Insider 3/6 Months : 108.4 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
3,017 |
7,892 |
32,818 |
38,850 |
Total Buy Value |
$10,110 |
$31,836 |
$72,846 |
$80,715 |
Total People Bought |
4 |
4 |
4 |
4 |
Total Buy Transactions |
120 |
368 |
684 |
736 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2025-07-20 |
2025-04-18 |
2024-10-18 |
2023-10-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Young Caroline |
Director |
|
2025-09-30 |
4 |
A |
$3.12 |
$19 |
D/D |
6 |
33,030 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2025-09-30 |
4 |
A |
$3.12 |
$41 |
D/D |
13 |
5,700,284 |
|
- |
|
Jones James |
Director |
|
2025-09-30 |
4 |
A |
$3.12 |
$41 |
D/D |
13 |
44,192 |
|
- |
|
Krogulski Kenneth |
Director |
|
2025-09-30 |
4 |
A |
$3.12 |
$212 |
D/D |
68 |
291,031 |
|
- |
|
Young Caroline |
Director |
|
2025-09-29 |
4 |
A |
$3.14 |
$19 |
D/D |
6 |
33,024 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2025-09-29 |
4 |
A |
$3.14 |
$41 |
D/D |
13 |
5,700,271 |
|
- |
|
Jones James |
Director |
|
2025-09-29 |
4 |
A |
$3.14 |
$41 |
D/D |
13 |
44,179 |
|
- |
|
Krogulski Kenneth |
Director |
|
2025-09-29 |
4 |
A |
$3.14 |
$214 |
D/D |
68 |
290,963 |
|
- |
|
Young Caroline |
Director |
|
2025-09-26 |
4 |
A |
$3.05 |
$12 |
D/D |
4 |
33,018 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2025-09-26 |
4 |
A |
$3.05 |
$37 |
D/D |
12 |
5,700,258 |
|
- |
|
Jones James |
Director |
|
2025-09-26 |
4 |
A |
$3.05 |
$37 |
D/D |
12 |
44,166 |
|
- |
|
Krogulski Kenneth |
Director |
|
2025-09-26 |
4 |
A |
$3.05 |
$189 |
D/D |
62 |
290,895 |
|
- |
|
Young Caroline |
Director |
|
2025-09-25 |
4 |
A |
$3.10 |
$12 |
D/D |
4 |
33,014 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2025-09-25 |
4 |
A |
$3.10 |
$37 |
D/D |
12 |
5,700,246 |
|
- |
|
Jones James |
Director |
|
2025-09-25 |
4 |
A |
$3.10 |
$37 |
D/D |
12 |
44,154 |
|
- |
|
Krogulski Kenneth |
Director |
|
2025-09-25 |
4 |
A |
$3.10 |
$192 |
D/D |
62 |
290,833 |
|
- |
|
Young Caroline |
Director |
|
2025-09-24 |
4 |
A |
$3.10 |
$12 |
D/D |
4 |
33,010 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2025-09-24 |
4 |
A |
$3.10 |
$37 |
D/D |
12 |
5,700,234 |
|
- |
|
Jones James |
Director |
|
2025-09-24 |
4 |
A |
$3.10 |
$37 |
D/D |
12 |
44,142 |
|
- |
|
Krogulski Kenneth |
Director |
|
2025-09-24 |
4 |
A |
$3.10 |
$192 |
D/D |
62 |
290,771 |
|
- |
|
Young Caroline |
Director |
|
2025-09-23 |
4 |
A |
$3.21 |
$13 |
D/D |
4 |
33,006 |
|
- |
|
Kazimi A J |
Chairman and CEO |
|
2025-09-23 |
4 |
A |
$3.21 |
$39 |
D/D |
12 |
5,700,222 |
|
- |
|
Jones James |
Director |
|
2025-09-23 |
4 |
A |
$3.21 |
$39 |
D/D |
12 |
44,130 |
|
- |
|
Krogulski Kenneth |
Director |
|
2025-09-23 |
4 |
A |
$3.21 |
$199 |
D/D |
62 |
290,709 |
|
- |
|
Young Caroline |
Director |
|
2025-09-22 |
4 |
A |
$3.29 |
$13 |
D/D |
4 |
33,002 |
|
- |
|
3488 Records found
|
|
Page 1 of 140 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|